Arena Pharmaceuticals

Pfizer kicks newly acquired meds out of Arena as part of midstage cleaning
Pfizer kicks newly acquired meds out of Arena as part of midstage cleaning
Fierce Biotech
Pfizer
Arena Pharmaceuticals
etrasimod
M&A
Flag link:
Pfizer's Arena goal? Get out of the way and don't 'break the new toy'
Pfizer's Arena goal? Get out of the way and don't 'break the new toy'
Fierce Biotech
Pfizer
M&A
Arena Pharmaceuticals
Flag link:
Pfizer's $6.7 Billion Bet Could Be About to Pay Off Big Time
Pfizer's $6.7 Billion Bet Could Be About to Pay Off Big Time
Motley Fool
Pfizer
M&A
Arena Pharmaceuticals
etrasimod
clinical trials
ulcerative colitis
Flag link:
Pfizer's $7B ulcerative colitis drug racks up another phase 3 win, laying the groundwork for approval filings
Pfizer's $7B ulcerative colitis drug racks up another phase 3 win, laying the groundwork for approval filings
Fierce Biotech
Pfizer
ulcerative colitis
etrasimod
Arena Pharmaceuticals
clinical trials
Flag link:
The first big test of Pfizer’s Arena buyout clears a PhIII in bid to catch up to Zeposia
The first big test of Pfizer’s Arena buyout clears a PhIII in bid to catch up to Zeposia
Endpoints
Pfizer
Zeposia
Bristol Myers Squibb
Arena Pharmaceuticals
etrasimod
Flag link:
After slower-than-expected review, Pfizer and Arena to close buyout deal
After slower-than-expected review, Pfizer and Arena to close buyout deal
BioPharma Dive
Pfizer
Arena Pharmaceuticals
M&A
Flag link:
3 Clinical Trials to Watch in the First Half of 2022
3 Clinical Trials to Watch in the First Half of 2022
Motley Fool
clinical trials
Pfizer
Arena Pharmaceuticals
etrasimod
Roche
Alzheimer's disease
gantenerumab
AbbVie
cystic fibrosis
Flag link:
The top 10 biopharma M&A deals in 2021
The top 10 biopharma M&A deals in 2021
Fierce Pharma
M&A
CSL
Vifor
Jazz Pharmaeuticals
GW Pharma
Novo Nordisk
Dicerna
Horizon Therapeutics
Viela Bio
Perrigo
HRA Pharma
Sanofi
Kadmon
Merck
Acceleron
Pfizer
Arena Pharmaceuticals
Translate Bio
Trillium Therapeutics
Amgen
Five Prime Therapeutics
Flag link:
Biotech investors pray for a takeover miracle
Biotech investors pray for a takeover miracle
EP Vantage
M&A
biotech
Amylyx Pharmaceuticals
Arena Pharmaceuticals
AstraZeneca
Aurinia Pharmaceuticals
Biogen
Biohaven
Bristol Myers Squibb
Eli Lilly
GSK
Merck
Novartis
Novo Nordisk
Pfizer
Sanofi
Flag link:
10 clinical trials to watch in the first half of 2022
10 clinical trials to watch in the first half of 2022
BioPharma Dive
clinical trials
Pfizer
Arena Pharmaceuticals
etrasimod
Sanofi
GSK
vaccines
COVID-19
Roche
gantenerumab
AbbVie
Gilead Sciences
Trodelvy
Karuna Therapeutics
KarXT
Intercept Pharma
obeticholic acid
Allogene
ALLO-501a
Flag link:
Is Pfizer's Acquisition of Arena a Good Move for Investors?
Is Pfizer's Acquisition of Arena a Good Move for Investors?
Motley Fool
Pfizer
Arena Pharmaceuticals
M&A
Flag link:
Biopharma’s buyout year ends with a bang
Biopharma’s buyout year ends with a bang
EP Vantage
M&A
CSL
Vifor Pharma
Pfizer
Arena Pharmaceuticals
Flag link:
Tidy up your labs, biotech. Pfizer is coming with 'significant firepower' and cash to burn
Tidy up your labs, biotech. Pfizer is coming with 'significant firepower' and cash to burn
Fierce Biotech
Pfizer
biotech
M&A
Arena Pharmaceuticals
Flag link:
Arena, completing its turnaround, sells to Pfizer for nearly $7 billion
Arena, completing its turnaround, sells to Pfizer for nearly $7 billion
BioPharma Dive
Pfizer
M&A
Arena Pharmaceuticals
inflammation
etrasimod
Flag link:
An AstraZeneca spinout scores a buyout option from Arena
An AstraZeneca spinout scores a buyout option from Arena
BioPharma Dive
AstraZeneca
Aristea Therapeutics
M&A
Arena Pharmaceuticals
Flag link:
Arena's pain drug fails phase 2b, prompting review of 'strategic options'
Arena's pain drug fails phase 2b, prompting review of 'strategic options'
Fierce Biotech
Arena Pharmaceuticals
clinical trials
olorinab
IBS
Flag link:
Arena Pharma's R&D lead quits 6 months into the job, replaced by Alder CMO
Arena Pharma's R&D lead quits 6 months into the job, replaced by Alder CMO
Fierce Biotech
Arena Pharmaceuticals
R&D
Alder Biopharmaceuticals
Flag link:
Arena's lead drug misses on PhII in AD, thwacking stock, but company soldiers on into Phase III
Arena's lead drug misses on PhII in AD, thwacking stock, but company soldiers on into Phase III
Endpoints
Arena Pharmaceuticals
etrasimod
clinical trials
atopic dermatitis
Flag link:
Arena doses first subject in ELEVATE UC 12 phase 3 trial of Etrasimod in ulcerative colitis
Arena doses first subject in ELEVATE UC 12 phase 3 trial of Etrasimod in ulcerative colitis
Pharmaceutical Business Review
Arena Pharmaceuticals
clinical trials
etrasimod
ulcerative colitis
Flag link:
Why Arena Pharmaceuticals' Q2 Results Don't Matter
Why Arena Pharmaceuticals' Q2 Results Don't Matter
Motley Fool
earnings
Arena Pharmaceuticals
Refinitiv
Flag link:

Pages